Probiotics-derived metabolite ameliorates skin allergy by promoting differentiation of FOXP3+ regulatory T cells

Authors
Kang, H.-J.Kim, G.-C.Lee, C.-G.Park, S.Sharma, G.Verma, R.Im, S.-H.Kwon, H.-K.
Issue Date
2021-04
Publisher
Mosby Inc.
Citation
Journal of Allergy and Clinical Immunology, v.147, no.4, pp.1517 - 1521
Abstract
[No abstract available]
Keywords
probiotic agent; transcription factor FOXP3; Article; drug effect; drug efficacy; drug mechanism; human; immunomodulation; nonhuman; priority journal; regulatory T lymphocyte; skin allergy; contact hypersensitivity; Foxp3; Regulatory T cells; probiotics; metabolite; propionate; skin allergy; atopic dermatitis
ISSN
0091-6749
URI
https://pubs.kist.re.kr/handle/201004/117233
DOI
10.1016/j.jaci.2020.11.040
Appears in Collections:
KIST Article > 2021
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE